215 related articles for article (PubMed ID: 18345026)
21. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
[TBL] [Abstract][Full Text] [Related]
22. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
Eilon T; Barash I
BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived CCL5 does not contribute to breast cancer progression.
Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
25. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
26. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
[TBL] [Abstract][Full Text] [Related]
27. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer.
Bell-McGuinn KM; Garfall AL; Bogyo M; Hanahan D; Joyce JA
Cancer Res; 2007 Aug; 67(15):7378-85. PubMed ID: 17671208
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
30. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.
Ricciardelli C; Frewin KM; Tan Ide A; Williams ED; Opeskin K; Pritchard MA; Ingman WV; Russell DL
Am J Pathol; 2011 Dec; 179(6):3075-85. PubMed ID: 22001177
[TBL] [Abstract][Full Text] [Related]
31. [On the role of transcription factor family AP-2 for development and disease--lessons from mouse models].
Schorle H
Verh Dtsch Ges Pathol; 2007; 91():91-7. PubMed ID: 18314601
[TBL] [Abstract][Full Text] [Related]
32. Deletion of
Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
33. Macrophages regulate the angiogenic switch in a mouse model of breast cancer.
Lin EY; Li JF; Gnatovskiy L; Deng Y; Zhu L; Grzesik DA; Qian H; Xue XN; Pollard JW
Cancer Res; 2006 Dec; 66(23):11238-46. PubMed ID: 17114237
[TBL] [Abstract][Full Text] [Related]
34. Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.
Pylayeva Y; Guo W; Giancotti FG
Methods Enzymol; 2007; 426():439-61. PubMed ID: 17697895
[TBL] [Abstract][Full Text] [Related]
35. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
36. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
37. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.
Pedersen TX; Pennington CJ; Almholt K; Christensen IJ; Nielsen BS; Edwards DR; Rømer J; Danø K; Johnsen M
Carcinogenesis; 2005 Jul; 26(7):1233-40. PubMed ID: 15760918
[TBL] [Abstract][Full Text] [Related]
38. 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model.
Whitehead TL; Monzavi-Karbassi B; Jousheghany F; Artaud C; Elbein A; Kieber-Emmons T
Int J Oncol; 2005 Jul; 27(1):257-63. PubMed ID: 15942667
[TBL] [Abstract][Full Text] [Related]
39. Binding of 125I-labelled concanavalin A by cells from spontaneously arising murine mammary carcinomas and experimentally induced metastases.
Kumar RK; Price JE; Sargent NS; Tarin D
Anticancer Res; 1983; 3(5):343-6. PubMed ID: 6651235
[TBL] [Abstract][Full Text] [Related]
40. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
